Skip to content

Assessment of temperament (Mizaj) in women with Polycystic ovarian syndrome (PCOS) and non-polycystic ovarian syndrome Women

Assessment of Mizaj in women with polycystic ovarian syndrome and without polycystic ovarian syndrome: A case-control study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098886
Enrollment
150
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N832- Other and unspecified ovarian cysts

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria (Cases and Controls): 1. Women aged 15 40 years, both married and unmarried. 2. Willing to participate and provide informed oral consent (for minors, consent from parent/guardian will be obtained). Additional Criteria for Cases: Diagnosed with PCOS based on the Rotterdam criteria, meeting at least two of the following: Oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism, Polycystic ovaries morphology on ultrasonography. Controls: Women without PCOS, matched for age ( 2 years) and BMI with the case group. Regular menstrual cycles and absence of clinical/laboratory evidence of hyperandrogenism or polycystic ovaries.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Participants with uncontrolled hypertension (Stage 2 hypertension more than 140/90 mmHg), uncontrolled diabetes mellitus (FBS more than 130mg/dl or PPBS more than 180mg/dl or RBS more than 200mg/dl or HbA1c more than 7.00%), hyperprolactinemia, uncontrolled thyroid diseases (more than 5.5 mU/L). 2. Participants using oral contraceptives, anti-inflammatory drugs or insulin sensitizing drugs in last 2 months will be excluded. 3. Incomplete questionnaire response (more than 10% missing data).

Design outcomes

Primary

MeasureTime frame
To determine whether general and uterine Mizaj types serve as potential risk factors for the presence of Polycystic Ovary Syndrome (PCOS) in reproductive-aged women.Timepoint: The Mizaj will be assessed on first day

Secondary

MeasureTime frame
To evaluate whether specific Mizaj types contribute as risk factors to alterations in hormonal & inflammatory biomarkers among women with & without PCOS.Timepoint: It will be assessed on first day

Countries

India

Contacts

Public ContactArshiya Sultana

National Institute of Unani Medicine

ansarisadafaabid1998@gmail.com9518922035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026